TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Ursolic acid, Doxorubicin
Phytochemical Name Ursolic acid (PubChem CID: 64945 )
Anticancer drug Name Doxorubicin (PubChem CID: 31703 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 191
Pair Name Ursolic acid, Doxorubicin
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Biological Phenomena Induction-->Blockade of cell cycle in G0/G1 phase
Gene Regulation Down-regulation Phosphorylation MTOR hsa2475
Down-regulation Expression PPARGC1A hsa10891
Up-regulation Phosphorylation PRKAA1 hsa5562
Up-regulation Expression ROS1 hsa6098
Down-regulation Expression SLC2A1 hsa6513
In Vitro Model NCI-ADR-RES High grade ovarian serous adenocarcinoma Homo sapiens (Human) CVCL_1452
Result Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction
Combination Pair ID: 1011
Pair Name Ursolic acid, Doxorubicin
Disease Info [ICD-11: 2B91] Colorectal cancer Investigative
Gene Regulation Down-regulation Phosphorylation AKT1 hsa207
Up-regulation Cleavage CASP9 hsa842
Down-regulation Expression CCN2 hsa1490
Down-regulation Expression CCND1 hsa595
Up-regulation Expression CDH1 hsa999
Down-regulation Expression CDK4 hsa1019
Down-regulation Expression CDK6 hsa1021
Down-regulation Phosphorylation GSK3B hsa2932
Down-regulation Expression MMP9 hsa4318
Up-regulation Phosphorylation MOB1A hsa55233
Up-regulation Expression MST1 hsa4485
Up-regulation Expression MST2 hsa6788
Down-regulation Expression MYC hsa4609
Up-regulation Cleavage PARP1 hsa142
Down-regulation Expression PLAU hsa5328
Up-regulation Expression SAV1 hsa60485
Up-regulation Phosphorylation YAP1 hsa10413
In Vitro Model HCT 116 Colon carcinoma Homo sapiens (Human) CVCL_0291
HT-29 Colon adenocarcinoma Homo sapiens (Human) CVCL_0320
In Vivo Model HCT116 cells (1×10⁷) in 100 µl Matrigel were injected into the flank area of the mice.
Result UA may be a novel anticancer strategy and could be considered for investigation as a complementary chemotherapy agent in the future.
03. Reference
No. Title Href
1 Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction. Biochem Pharmacol. 2022 Nov;205:115278. doi: 10.1016/j.bcp.2022.115278. Click
2 Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Mol Med Rep. 2023 Jan;27(1):11. doi: 10.3892/mmr.2022.12898. Click
It has been 26268 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP